NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
0.6557
+0.0449 (7.35%)
Apr 24, 2026, 2:09 PM EDT - Market open
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $5.56 million as of April 24, 2026. Its market cap has decreased by -72.29% in one year.
Market Cap
5.56M
Enterprise Value
8.36M
1-Year Change
-72.29%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has decreased from $19.59M to $5.56M, a decrease of -71.63%. That is a compound annual growth rate of -25.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 5.18M | -60.51% |
| Dec 31, 2025 | 13.11M | -60.90% |
| Dec 31, 2024 | 33.53M | 175.32% |
| Dec 29, 2023 | 12.18M | 74.85% |
| Dec 30, 2022 | 6.97M | -52.05% |
| Dec 31, 2021 | 14.52M | -25.85% |
| Dec 22, 2021 | 19.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nephros | 30.55M |
| Harvard Bioscience | 28.98M |
| Milestone Scientific | 25.36M |
| Femasys | 25.18M |
| Retractable Technologies | 18.89M |
| Jin Medical International | 16.79M |
| Regentis Biomaterials | 15.38M |
| Bionano Genomics | 13.98M |